EFEMP2 has been regarded as an auspicious biomarker for CRC early detection [82], and knockdown of EFEMP2 could inhibit the proliferation and invasion of CRC cells via ERK1/2 pathway [83]. The gene discussed is MAPK3; the disease is colorectal carcinoma.